Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01828307 · ClinicalTrials.gov registry record · NA
Exercise: Addressing Stress in Relapse Prevention for Substance Use Disorders
A NA study, sponsored by St. Louis University.
- Completed
- Registry status
- NA
- Development phase
- 147
- Enrollment target
NCT01828307: Completed NA study, sponsored by St. Louis University.
NCT01828307 is a NA study that has completed, run by St. Louis University. The registered enrollment target is 147 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01828307, a NA study, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- NA
- Development phase
- 147 participants
- Enrollment target
Study Summary
Relapse contributes significantly to the chronicity of substance use disorders, one of the most costly medical/mental health problems facing our nation. The incorporation of exercise into relapse prevention efforts will address stress, a critical factor in relapse, provide other health benefits, and improve overall quality of life. Combined, these changes will reduce the risk of relapse to substance use while also lessening the burden of this psychiatric disorder upon society
Primary Outcome
Relapse is assessed during the duration of the study and is a time to event variable so it will be assess over time. Relapse is defined as drinking alcohol in excess of the National Institute on Alcohol Abuse and Alcohol (NIAAA) at-risk guidelines.
Interventions
- BEHAVIORAL Contingency management
- BEHAVIORAL Motivational enhancement therapy (MET)
- BEHAVIORAL Standard Aftercare Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2013-04 |
| Est. Completion | 2019-03 |
| Phase | NA |
What the finished NCT01828307 record still lists
NCT01828307 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 3 interventions - of which Contingency management is the first listed.
NCT01828307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01828307 about?
NCT01828307 is a clinical study titled "Exercise: Addressing Stress in Relapse Prevention for Substance Use Disorders". Relapse contributes significantly to the chronicity of substance use disorders, one of the most costly medical/mental health problems facing our nation. The incorporation of exercise into relapse prevention efforts will address stress, a critical factor in relapse, provide other health benefits, and...
What is the current status of trial NCT01828307?
This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2013-04. Estimated completion is 2019-03.
What interventions are being tested in trial NCT01828307?
The interventions under investigation include: Contingency management (BEHAVIORAL), Motivational enhancement therapy (MET) (BEHAVIORAL), Standard Aftercare Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01828307?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01828307's enrollment target sits among peer trials
147 703rd of 2000 higher than 1,297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia